Related Experiment Video
Updated: Aug 14, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
Deepika Ahuja1, M Teresa Sáenz-Robles, James M Pipas
1Department of Biological Sciences, University of Pittsburgh, PA 15260, USA.
Abstract:
DNA tumor viruses such as simian virus 40 (SV40) express dominant acting oncoproteins that exert their effects by associating with key cellular targets and altering the signaling pathways they govern. Thus, tumor viruses have proved to be invaluable aids in identifying proteins that participate in tumorigenesis, and in understanding the molecular basis for the transformed phenotype. The roles played by the SV40-encoded 708 amino-acid large T antigen (T antigen), and 174 amino acid small T antigen (t antigen), in transformation have been examined extensively. These studies have firmly established that large T antigen's inhibition of the p53 and Rb-family of tumor suppressors and small T antigen's action on the pp2A phosphatase, are important for SV40-induced transformation. It is not yet clear if the Rb, p53 and pp2A proteins are the only targets through which SV40 transforms cells, or whether additional targets await discovery. Finally, expression of SV40 oncoproteins in transgenic mice results in effects ranging from hyperplasia to invasive carcinoma accompanied by metastasis, depending on the tissue in which they are expressed. Thus, the consequences of SV40 action on these targets depend on the cell type being studied. The identification of additional cellular targets important for transformation, and understanding the molecular basis for the cell type-specific action of the viral T antigens are two important areas through which SV40 will continue to contribute to our understanding of cancer.
Insights
Simian virus 40 (SV40) oncoproteins drive cancer by targeting key cellular proteins like p53 and Rb. Further research aims to uncover additional targets and understand SV40
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- DNA tumor viruses, like simian virus 40 (SV40), utilize oncoproteins to manipulate cellular pathways.
- SV40 oncoproteins, including large T antigen and small t antigen, are crucial for cellular transformation.
- Tumor viruses serve as vital tools for identifying cancer-promoting proteins and understanding tumorigenesis.
Purpose of the Study:
- To elucidate the roles of SV40 large T antigen and small t antigen in cellular transformation.
- To identify the cellular targets and signaling pathways affected by SV40 oncoproteins.
- To investigate the cell-type-specific mechanisms underlying SV40-induced oncogenesis.
Main Methods:
- Extensive examination of the functions of SV40 large T antigen and small t antigen.
- Analysis of SV40 oncoprotein interactions with cellular targets such as p53, Rb-family proteins, and pp2A phosphatase.
- Studies involving transgenic mice expressing SV40 oncoproteins to observe in vivo effects.
Main Results:
- SV40 large T antigen inhibits p53 and Rb-family tumor suppressors, while small t antigen affects pp2A phosphatase activity, both contributing to transformation.
- SV40 oncoprotein expression in transgenic mice can lead to diverse outcomes, from hyperplasia to invasive carcinoma with metastasis.
- The cellular consequences of SV40 oncoprotein action are dependent on the specific tissue and cell type.
Conclusions:
- SV40-induced transformation involves the targeting of critical tumor suppressors and phosphatases.
- Additional cellular targets of SV40 oncoproteins likely await discovery.
- Understanding the cell-type-specific mechanisms of SV40 action is key to advancing cancer research.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
TGF - β Signaling Pathway

